信息搜索
信息关键字：药
  

共有5246条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]

·天马国药2022年上半年净利1211.91万同比下滑18.01%业务规模收缩2022-8-23 11:37:20
·减持比例超5%红线后未按要求信披尔康制药实际控制人之一致行动人收监管函2022-8-23 11:36:44
·减持行为不符合规定*ST吉药实控人卢忠奎收监管函2022-8-23 11:13:12
·创业板注册制改革两周年九十六家生物医药企业云集创业板“聚光灯”效应凸显2022-8-23 10:11:42
·23股获陆股通增仓超50%精华制药增幅最大2022-8-23 9:17:50
·重要子公司股权被“偷卖”未名医药再收关注函2022-8-23 9:04:56
·云南中药2022年上半年亏损438.7万同比亏损减少销售费用减少2022-8-23 8:09:36
·葛兰看空医药了？假的！“李鬼”频繁出没行业掀起“打假”潮2022-8-23 8:05:19
·股票型ETF份额增长医药半导体板块获青睐2022-8-23 7:43:54
·博大制药2022年上半年亏损376.78万同比亏损减少营业利润比去年同期增加2022-8-23 0:23:56
·横琴发布“稳经济30条”：加快出台支持生物医药大健康产业发展的政策措施培育发展元宇宙等新业态2022-8-22 23:15:48
·证监会批了！2600亿“药界茅台”增发H股，最多7843.43万股！要干这些事...2022-8-22 22:43:08
·大佛药业2022年上半年净利1522.2万同比增长16.01%销售费用减少2022-8-22 22:07:03
·股票行情快报：汉森制药8月22日主力资金净买入157.89万元2022-8-22 21:09:08
·证监会同意泓博医药IPO注册2022-8-22 18:36:52
·药明康德：增发境外上市外资股（H股）获得中国证监会批复2022-8-22 18:07:35
·新兴药业2022年上半年净利1185.9万同比减少33.04%客户需求降低2022-8-22 17:51:25
·药明康德：增发境外上市外资股（H股）获得证监会批复2022-8-22 17:16:29
·汇宇制药：多西他赛注射液获得德国上市许可2022-8-22 16:47:26
·打造适配生态，创业板崛起生物医药创新高地2022-8-22 11:04:53

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]